Those who took Zytiga had a three-year survival rate of 83%. For men with CSPC, drug therapy that included Zytiga lowered the risk of death by 34% over 52 months.Īnother study looked at men with either metastatic CRPC or CSPC who were starting hormone therapy for the first time. In clinical studies of men with metastatic CRPC, taking Zytiga with prednisone in addition to standard hormone therapy prolonged life by about 4.5 months. In some cases, you’ll take Zytiga and prednisone with a different type of hormone therapy to further lower testosterone levels. You’ll take Zytiga with a corticosteroid (prednisone) to reduce the risk of certain side effects. Zytiga comes as an oral tablet that you take once a day. Reduced levels of male hormones, such as testosterone, help slow or stop the growth of prostate cancer cells. It’s a type of medication used in hormone therapy, which is a treatment that lowers the level of male hormones in the body. Zytiga contains the drug abiraterone acetate. High-risk castration-sensitive cancer still responds to lowered testosterone levels but requires more aggressive treatment. Prostate cancer is considered castration-resistant if the cancer continues to grow or spread even with therapy or surgery to lower testosterone levels. Testosterone usually plays a role in stimulating prostate cancer growth. The word “castration” refers to the lowering of testosterone levels. Both of these cancers are considered advanced. Metastatic means the cancer has spread to other parts of the body. metastatic high-risk castration-sensitive prostate cancer (CSPC).metastatic castration-resistant prostate cancer (CRPC).It’s used to treat two types of prostate cancer: Zytiga is a brand-name prescription medication.
0 kommentar(er)
